A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,411,608 shares of AVTE stock, worth $3.67 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,411,608
Previous 1,411,608 -0.0%
Holding current value
$3.67 Million
Previous $2.34 Million 25.91%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.41 - $30.75 $1.99 Million - $43.4 Million
1,411,608 New
1,411,608 $2.34 Million
Q4 2021

Feb 14, 2022

SELL
$9.14 - $21.54 $6.53 Million - $15.4 Million
-714,285 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$22.83 - $22.83 $16.3 Million - $16.3 Million
714,285 New
714,285 $16.3 Million

Others Institutions Holding AVTE

About Aerovate Therapeutics, Inc.


  • Ticker AVTE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,448,100
  • Market Cap $63.6M
  • Description
  • Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...
More about AVTE
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.